ROCKWELL MEDICAL, INC.: 10-Q filed 2015-05-07

Name: ROCKWELL MEDICAL, INC.: 10-Q filed 2015-05-07
Creator: ROCKWELL MEDICAL, INC.

What ROCKWELL MEDICAL, INC. reported in its quarterly report filed 2015-05-07 (fiscal Q1 2015): 34 published measures, 70 facts as tagged in accession 0001104659-15-035646.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-05-07
Fiscal period: fiscal Q1 2015
Accession: 0001104659-15-035646 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ROCKWELL MEDICAL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-03-31	97,160,684	USD
At 2014-12-31	97,999,716	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-03-31	67,821,665	USD
At 2014-12-31	68,702,794	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-03-31	63,332,646	USD
At 2014-12-31	65,800,451	USD
At 2014-03-31	661,117	USD
At 2013-12-31	11,881,451	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-3,699,194	USD	90
2014-01-01 to 2014-03-31	-7,805,526	USD	90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-3,313,784	USD	90
2014-01-01 to 2014-03-31	-10,365,177	USD	90

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	918,884	USD	90
2014-01-01 to 2014-03-31	1,474,725	USD	90

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-72,905	USD	90
2014-01-01 to 2014-03-31	-2,329,882	USD	90

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-03-31	-183,816,920	USD
At 2014-12-31	-180,117,726	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	49,667,434	shares	90
2014-01-01 to 2014-03-31	39,812,820	shares	90

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	49,667,434	shares	90
2014-01-01 to 2014-03-31	39,812,820	shares	90

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-0.07	USD/shares	90
2014-01-01 to 2014-03-31	-0.2	USD/shares	90

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-0.07	USD/shares	90
2014-01-01 to 2014-03-31	-0.2	USD/shares	90

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2015-03-31	1,401,292	USD
At 2014-12-31	1,496,912	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	3,292,584	USD	90
2014-01-01 to 2014-03-31	2,174,212	USD	90

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-3,813,009	USD	90
2014-01-01 to 2014-03-31	-7,025,438	USD	90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-03-31	94,005,495	USD
At 2014-12-31	94,707,149	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-03-31	10,339,726	USD
At 2014-12-31	9,804,402	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2015-03-31	5,137,855	USD
At 2014-12-31	5,294,515	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2015-03-31	920,745	USD
At 2014-12-31	920,745	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2015-03-31	4,665,831	USD
At 2014-12-31	4,472,002	USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2015-03-31	5,196,006	USD
At 2014-12-31	3,920,185	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	2,312,343	USD	90
2014-01-01 to 2014-03-31	1,679,958	USD	90

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	5,325,761	USD	90
2014-01-01 to 2014-03-31	4,090,199	USD	90

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	799,591	USD	90
2014-01-01 to 2014-03-31	4,615,197	USD	90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-03-31	50,269,383	shares
At 2014-12-31	50,284,007	shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2015-03-31	-127,471	USD
At 2014-12-31	-197,669	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2015-03-31	290,929	USD
At 2014-12-31	332,686	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2015-03-31	542,223	USD
At 2014-12-31	542,224	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2015-03-31	4,863,079	USD
At 2014-12-31	4,325,997	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-3,699,194	USD	90
2014-01-01 to 2014-03-31	-7,805,526	USD	90

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-3,628,996	USD	90
2014-01-01 to 2014-03-31	-7,771,666	USD	90

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	207,858	USD	90
2014-01-01 to 2014-03-31	257,761	USD	90

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	1,275,821	USD	90
2014-01-01 to 2014-03-31	110,180	USD	90

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-156,661	USD	90
2014-01-01 to 2014-03-31	-3,552,886	USD	90

Inspect the source

Entity: ROCKWELL MEDICAL, INC. / CIK 0001041024
Captured: 2026-09-20T05:15:52.429Z
SEC response SHA-256: 88e8b83e4e95fda016bcc9a5dced4522c975c40fff65ebdbda5ac42b28ba4fb6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001041024.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))